Both in Biotechnology
VivoSim Labs vs Silexion Therapeutics
Over the past year VIVS returned −93.9% and SLXN returned −99.5%; their daily moves had a correlation of 0.07.
VIVS −93.9% SLXN −99.5%Growth of $1, one year, split-adjusted
| Metric | VIVS | SLXN |
|---|---|---|
| Price | $0.1436 | $0.1533 |
| Market cap | $1.9M | $2.2M |
| Today | −6.33% | +3.41% |
| 1 month | −30.4% | −42.3% |
| 6 months | −89.9% | −97.5% |
| Year to date | −92.1% | −99.2% |
| 1 year | −94.7% | −99.5% |
| Revenue growth (YoY) | −51.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −7433.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 17.2× | — |
| Net cash | $1.7M | — |
| Dividend yield | — | — |
| Volatility (60d) | 75.8% | 238.3% |
| Short % of float | 4.0% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).